An Open-Label, Single Dose, Pharmacokinetic Study of AL-60371 Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery
Latest Information Update: 16 Oct 2014
At a glance
- Drugs Finafloxacin (Primary)
- Indications Bacterial infections; Postoperative infections
- Focus Pharmacokinetics
- Sponsors Alcon
- 12 Oct 2014 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Sep 2014 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
- 17 Sep 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.